3/5
03:28 pm
sny
Amgen Faces Rocatinlimab Halt And Rethinks Pipeline And Capital Priorities [Yahoo! Finance]
Low
Report
Amgen Faces Rocatinlimab Halt And Rethinks Pipeline And Capital Priorities [Yahoo! Finance]
3/5
02:18 pm
sny
Podcast: Sanofi's head of clinical supply chain operations on evolving the clinical trial supply model [Yahoo! Finance]
Low
Report
Podcast: Sanofi's head of clinical supply chain operations on evolving the clinical trial supply model [Yahoo! Finance]
3/5
08:34 am
sny
Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors [Yahoo! Finance]
Low
Report
Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors [Yahoo! Finance]
3/5
03:42 am
sny
Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director [Yahoo! Finance]
Medium
Report
Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director [Yahoo! Finance]
3/5
03:16 am
sny
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
Medium
Report
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
3/4
05:55 pm
sny
Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight [Yahoo! Finance]
Low
Report
Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight [Yahoo! Finance]
3/4
02:29 pm
sny
Sanofi bets on Sino Biopharm's transplant drug in $1.5bn licensing deal [Yahoo! Finance]
Low
Report
Sanofi bets on Sino Biopharm's transplant drug in $1.5bn licensing deal [Yahoo! Finance]
3/4
01:01 pm
sny
Press Release: Filing of an amendment to the French “Document d'Enregistrement Universel” containing the Annual Financial Report [Yahoo! Finance]
Low
Report
Press Release: Filing of an amendment to the French “Document d'Enregistrement Universel” containing the Annual Financial Report [Yahoo! Finance]
3/4
12:30 pm
sny
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
Low
Report
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
3/4
07:00 am
sny
Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit [Seeking Alpha]
Low
Report
Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit [Seeking Alpha]
3/3
08:42 pm
sny
Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan [Yahoo! Finance]
Low
Report
Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan [Yahoo! Finance]
3/3
12:56 pm
sny
Pharma rings the changes as CEO shake-up continues [Yahoo! Finance]
Low
Report
Pharma rings the changes as CEO shake-up continues [Yahoo! Finance]
3/3
09:53 am
sny
7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036 [Yahoo! Finance]
Low
Report
7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036 [Yahoo! Finance]
3/3
08:02 am
sny
EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 2026 [Yahoo! Finance]
Low
Report
EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 2026 [Yahoo! Finance]
3/3
04:54 am
sny
AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0 [Yahoo! Finance]
Low
Report
AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0 [Yahoo! Finance]
3/2
03:32 pm
sny
Sanofi (SNY) and Regeneron's Dupixent Recommended for EU Approval [Yahoo! Finance]
Low
Report
Sanofi (SNY) and Regeneron's Dupixent Recommended for EU Approval [Yahoo! Finance]
3/2
01:20 pm
sny
Moderna's dual Covid-flu vaccine poised for EMA approval on positive CHMP take [Yahoo! Finance]
Low
Report
Moderna's dual Covid-flu vaccine poised for EMA approval on positive CHMP take [Yahoo! Finance]
3/2
01:31 am
sny
Press Release: Sanofi's rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease [Yahoo! Finance]
Low
Report
Press Release: Sanofi's rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease [Yahoo! Finance]
3/2
01:00 am
sny
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
Low
Report
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
2/28
10:15 am
sny
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis [Yahoo! Finance]
Low
Report
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis [Yahoo! Finance]
2/27
12:13 pm
sny
Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof [Seeking Alpha]
Low
Report
Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof [Seeking Alpha]
2/27
10:42 am
sny
Is Sanofi (ENXTPA:SAN) Offering An Opportunity After A 19.5% One Year Share Price Fall [Yahoo! Finance]
Low
Report
Is Sanofi (ENXTPA:SAN) Offering An Opportunity After A 19.5% One Year Share Price Fall [Yahoo! Finance]
2/27
09:05 am
sny
New sleeping sickness pill gets nod, paving the way for use in Africa [Yahoo! Finance Canada]
Low
Report
New sleeping sickness pill gets nod, paving the way for use in Africa [Yahoo! Finance Canada]
2/27
07:22 am
sny
Press Release: Sanofi and Regeneron's Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment [Yahoo! Finance]
Low
Report
Press Release: Sanofi and Regeneron's Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment [Yahoo! Finance]
2/27
07:03 am
sny
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
Low
Report
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment